199 related articles for article (PubMed ID: 21048156)
1. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
Pillozzi S; Masselli M; De Lorenzo E; Accordi B; Cilia E; Crociani O; Amedei A; Veltroni M; D'Amico M; Basso G; Becchetti A; Campana D; Arcangeli A
Blood; 2011 Jan; 117(3):902-14. PubMed ID: 21048156
[TBL] [Abstract][Full Text] [Related]
2. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
3. Physical and functional interaction between integrins and hERG1 channels in cancer cells.
Pillozzi S; Arcangeli A
Adv Exp Med Biol; 2010; 674():55-67. PubMed ID: 20549940
[TBL] [Abstract][Full Text] [Related]
4. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.
Pillozzi S; Brizzi MF; Bernabei PA; Bartolozzi B; Caporale R; Basile V; Boddi V; Pegoraro L; Becchetti A; Arcangeli A
Blood; 2007 Aug; 110(4):1238-50. PubMed ID: 17420287
[TBL] [Abstract][Full Text] [Related]
5. The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.
Becchetti A; Crescioli S; Zanieri F; Petroni G; Mercatelli R; Coppola S; Gasparoli L; D'Amico M; Pillozzi S; Crociani O; Stefanini M; Fiore A; Carraresi L; Morello V; Manoli S; Brizzi MF; Ricci D; Rinaldi M; Masi A; Schmidt T; Quercioli F; Defilippi P; Arcangeli A
Sci Signal; 2017 Apr; 10(473):. PubMed ID: 28377405
[TBL] [Abstract][Full Text] [Related]
6. The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration.
Li H; Du YM; Guo L; Jie S; Zhang S; Du W; Chen X; Liu W; Fan L; Zhu J; Zou A; Huang S
Exp Cell Res; 2009 Aug; 315(13):2256-64. PubMed ID: 19409379
[TBL] [Abstract][Full Text] [Related]
7. hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.
Crociani O; Zanieri F; Pillozzi S; Lastraioli E; Stefanini M; Fiore A; Fortunato A; D'Amico M; Masselli M; De Lorenzo E; Gasparoli L; Chiu M; Bussolati O; Becchetti A; Arcangeli A
Sci Rep; 2013 Nov; 3():3308. PubMed ID: 24270902
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers.
Duranti C; Iorio J; Lottini T; Lastraioli E; Crescioli S; Bagni G; Lulli M; Capitani C; Bouazzi R; Stefanini M; Carraresi L; Iamele L; De Jonge H; Arcangeli A
Mol Cancer Ther; 2021 Aug; 20(8):1338-1349. PubMed ID: 34045227
[TBL] [Abstract][Full Text] [Related]
9. Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
Zheng F; Li H; Du W; Huang S
Hematology; 2011 May; 16(3):177-84. PubMed ID: 21669058
[TBL] [Abstract][Full Text] [Related]
10. Human ether-a-go-go-related gene K+ channels regulate shedding of leukemia cell-derived microvesicles.
Zheng F; Li J; Du W; Wang N; Li H; Huang S
Leuk Lymphoma; 2012 Aug; 53(8):1592-8. PubMed ID: 22292854
[TBL] [Abstract][Full Text] [Related]
11. Targeting the hERG1 and β1 integrin complex for cancer treatment.
Arcangeli A; Iorio J; Duranti C
Expert Opin Ther Targets; 2024 Mar; 28(3):145-157. PubMed ID: 38372580
[TBL] [Abstract][Full Text] [Related]
12. Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.
Pillozzi S; Bernini A; Spiga O; Lelli B; Petroni G; Bracci L; Niccolai N; Arcangeli A
Oncol Rep; 2019 Jan; 41(1):312-324. PubMed ID: 30365110
[TBL] [Abstract][Full Text] [Related]
13. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
[TBL] [Abstract][Full Text] [Related]
14. The Link between Inactivation and High-Affinity Block of hERG1 Channels.
Wu W; Gardner A; Sanguinetti MC
Mol Pharmacol; 2015 Jun; 87(6):1042-50. PubMed ID: 25855787
[TBL] [Abstract][Full Text] [Related]
15. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling.
Cherubini A; Hofmann G; Pillozzi S; Guasti L; Crociani O; Cilia E; Di Stefano P; Degani S; Balzi M; Olivotto M; Wanke E; Becchetti A; Defilippi P; Wymore R; Arcangeli A
Mol Biol Cell; 2005 Jun; 16(6):2972-83. PubMed ID: 15800067
[TBL] [Abstract][Full Text] [Related]
16. The role of potassium channels in tumours of the gastrointestinal tract: a focus on the human ether-à-go-go related gene 1 channels.
Arcangeli A; Duranti C; Iorio J; Lastraioli E
J Physiol; 2023 May; 601(9):1597-1610. PubMed ID: 36215066
[TBL] [Abstract][Full Text] [Related]
17. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
[TBL] [Abstract][Full Text] [Related]
18. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
19. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
20. Targeting ion channels in leukemias: a new challenge for treatment.
Arcangeli A; Pillozzi S; Becchetti A
Curr Med Chem; 2012; 19(5):683-96. PubMed ID: 22204341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
